Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive PropertiesChristian P. Larsen, Robert Peach, Dan Anderson et al.|American Journal of Transplantation|2005Cited by 708